Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder.
10.3346/jkms.2011.26.9.1191
- Author:
Ji Hye YIM
1
;
Jong Ho YOON
;
Sun A KIM
;
Won Gu KIM
;
Min Ji JEON
;
Ji Min HAN
;
Tae Yon SUNG
;
Tae Yong KIM
;
Won Bae KIM
;
Suck Joon HONG
;
Young Kee SHONG
;
Gyungyub GONG
Author Information
1. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
X-linked Inhibitor of Apoptosis Protein;
Papillary Thyroid Carcinoma;
Thyroid Neoplasms;
Lymph Nodes;
Metastasis
- MeSH:
Adult;
Antibodies, Monoclonal/immunology;
Diagnosis, Differential;
Female;
*Gene Expression Regulation, Neoplastic;
Humans;
Immunohistochemistry;
Lymphatic Metastasis/diagnosis;
Male;
Middle Aged;
Neoplasm Staging;
Thyroid Neoplasms/epidemiology/metabolism/*pathology;
X-Linked Inhibitor of Apoptosis Protein/immunology/*metabolism
- From:Journal of Korean Medical Science
2011;26(9):1191-1195
- CountryRepublic of Korea
- Language:English
-
Abstract:
X-linked inhibitor of apoptosis protein (XIAP) is associated with tumor genesis, growth, progression and metastasis, and acts by blocking caspase-mediated apoptosis. In the present study, we sought to evaluate the expression patterns of XIAP in various neoplastic thyroid disorders and determine the association between XIAP expression and clinicopathologic factors. Expression of XIAP was evaluated with immunohistochemical staining using monoclonal anti-XIAP in 164 specimens of conventional papillary thyroid carcinoma (PTC) and 53 specimens of other malignant or benign thyroid tumors. XIAP positivity was observed in 128 (78%) of the 164 conventional PTC specimens. Positive rates of XIAP expression in follicular variant PTC, follicular, medullary, poorly differentiated, and anaplastic thyroid carcinoma specimens were 20%, 25%, 38%, 67%, and 38%, respectively. Six nodular hyperplasia specimens were negative and 1 of 7 follicular adenomas (8%) was positive for XIAP. Lateral neck lymph node metastases were more frequent in patients negative for XIAP expression (P = 0.01). Immunohistochemical staining for XIAP as a novel molecular marker may thus be helpful in the differential diagnosis of thyroid cancer. Moreover, high XIAP expression in conventional PTC is strongly associated with reduced risk of lateral neck lymph node metastasis.
